Anzeige
Mehr »
Dienstag, 02.06.2026 - Börsentäglich über 12.000 News
Entsteht hier die nächste Quantum-Story?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A112C8 | ISIN: FR0010120402 | Ticker-Symbol: 941
Frankfurt
02.06.26 | 21:41
0,670 Euro
-15,19 % -0,120
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
THERACLION SA Chart 1 Jahr
5-Tage-Chart
THERACLION SA 5-Tage-Chart
RealtimeGeldBriefZeit
0,6790,71622:09

Aktuelle News zur THERACLION Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoTheraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein SpeedPulse Were Presented229Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601718811/en/Illustration of Sonovein with new robotics SpeedPulse Theraclion...
► Artikel lesen
11.05.Theraclion Announces the Strong Success of Its Oversubscribed Capital Increase291Capital increase of a gross amount of 6 million Issue of 12,484,467 BSA enabling an additional fundraising of 2 million Regulatory News: This press release and the information it contains...
► Artikel lesen
THERACLION Aktie jetzt für 0€ handeln
28.04.Theraclion's non-invasive varicose treatment poised for FDA decision2
23.04.XFRA NEW INSTRUMENTS AVAILABLE ON 23.04.2026333The following instruments on XETRA do have their first trading 23.04.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.04.2026 Aktien 1 ID1000132806 PT Multi Bintang Indonesia...
► Artikel lesen
20.04.Theraclion Announces the Launch of a Capital Increase Through the Issuance of ABSA (Shares With Share Warrants Attached), With Preferential Subscription Rights for Existing Shareholders, for a Gross Amount of €6 Million, Secured by Subscription...597Subscription price: €0.48 per share, representing a nominal discount of 3.52% to the closing share price as of April 17, 2026, and a discount of 8.60% when taking into account the theoretical...
► Artikel lesen
16.04.Theraclion Publishes Its 2025 Financial Results and Provides an Update on Its Outlook478Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
29.01.Theraclion Delivers a Structuring Year in 2025 and Prepares to Scale up421Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
09.12.25Theraclion Announces Sonovein FDA Submission Following a Strong Year of Regulatory and Clinical Achievements582Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
29.10.25Theraclion Reports Major Recent Developments and Announces Its 2025 Half-Year Financial Results516Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
21.10.25Theraclion Secures Key Chinese Certification, Advancing Toward Market Access in China394Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
10.10.25Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital463Article 223-16 du Règlement Général de l'Autorité des marchés financiers Regulatory News: Theraclion (Paris:ALTHE): Place de cotation: Euronext Growth Paris Éligible PEA PME Code ISIN:...
► Artikel lesen
24.09.25Theraclion: Sonovein Receives MDR Certification, Strengthening Its Commercial Potential432Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
15.09.25Theraclion Announces Successful U.S. FDA Pivotal Study With 96.8% Occlusion Rate392Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915148081/en/Sonovein redefines varicose vein treatment with advanced...
► Artikel lesen
25.07.25Theraclion Growth Up in S1 2025805Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250725366467/en/Sonovein®, the first and only non-invasive varicose veins...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1